Angela Thedinga's most recent trade in Nkarta Inc was a trade of 22,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Nkarta Inc | Angela Thedinga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
Nkarta Inc | Angela Thedinga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
Nkarta Inc | Angela Thedinga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 3,218 | 3,218 | - | - | Stock Option (right to buy) | |
Nkarta Inc | Angela Thedinga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
Adverum Biotechnologies Inc | Angela Thedinga | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
Adverum Biotechnologies Inc | Angela Thedinga | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
Adverum Biotechnologies Inc | Angela Thedinga | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) |